Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Some breast cancer chemotherapy can cause permanent hair loss.

There are various treatment options for frontal fibrosing alopecia.

The excimer laser is a promising and safe treatment for frontal fibrosing alopecia.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Forsythiaside-A, a natural substance, can protect against hair loss and is more effective than current treatments, potentially making it a good option for hair loss treatment.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Taking Vitamin D with clomiphene citrate significantly improves ovulation in women with Poly Cystic Ovary Syndrome.

The combination therapy effectively treats infertility in PCOS without major side effects.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib significantly improved skin and hair conditions without side effects.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.

A special clotrimazole varnish cured a siamang's persistent skin infection after 3 months.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Stopping fluvoxamine can reverse hair loss caused by the drug.

Diphencyprone therapy for hair loss can cause vitiligo.

FR-1 reduces skin scarring and promotes healing without harmful effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Recurrent furunculosis can be managed with antibiotics, decolonization, and decontamination, with potential future use of vaccines and bacteriophage therapy.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

A new combination of tadalafil and finasteride improves drug performance and stability.